Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C
- Conditions
- Rectal Cancer Dukes B, Dukes C
- Registration Number
- NCT00309517
- Lead Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Brief Summary
This clinical investigation examined the influence of preoperative radiotherapy in combination with postoperative 5-fluorouracil + leucovorin chemotherapy vs. 5-fluorouracil + leucovorin + MAb 17-1A chemo-immunotherapy on patients' local recurrence rate and overall survival time following surgery for rectal carcinoma Dukes B or C (T2-4, N0-3, M0).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 700
- Patients with histologically verified operable rectal cancer Dukes B and C (Stage II, T2-4, N0-3, M0), R0
- Age: 18-80 years
- Karnofsky Performance Status > 80
- Adequate bone marrow reserve (leukocytes > 4,000, thrombocytes > 105/mm3, Hb > 10g %), renal and hepatic functions (total bilirubin and creatinine < 1.25 x ULN)
- Colon cancer
- R1, R2; carcinosis peritonei
- Start of treatment > 42 days postop; other adjuvant radiotherapy, chemotherapy or immunotherapy
- Previous application of a murine or chimeric monoclonal antibody or antibody fragment
- Medical therapy with steroids, cyclosporin or antithymocyte globulin within 3 months pre-study
- Known hypersensitivity to animal protein
- Serious concomitant disease: HIV, chronically inflammatory intestine, diabetes mell. gravis, cerebral seizure disorder, et al.
- Pregnancy or lactation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Local recurrence-free survival Overall survival
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (8)
Hospital Baden
🇦🇹Baden bei Wien, Lower Austria, Austria
Hospital Hainburg
🇦🇹Hainburg, Lower Austria, Austria
Hospital Oberpullendorf
🇦🇹Oberpullendorf, Burgenland, Austria
Hospital Wiener Neustadt, Surgery
🇦🇹Wiener Neustadt, Lower Austria, Austria
Medical University of Graz, Oncology
🇦🇹Graz, Styria, Austria
General Hospital Linz
🇦🇹Linz, Upper Austria, Austria
Hospital BHB Linz
🇦🇹Linz, Upper Austria, Austria
Medical University of Vienna, General Hospital
🇦🇹Vienna, Austria